1. Market Research
  2. > Pharmaceutical Market Trends
Harnessing The Power Of Real World Data

Harnessing The Power Of Real World Data

  • January 2016
  • ID: 3612599
  • Format: PDF
  • Firstword Pharma

Summary


Introduction

How to collect and interpret the real world data that supports your brand and improves patient outcomes

Real world data is being employed across a wide spectrum of pharma’s activities and is proving itself in a range of research, clinical and commercial settings. But how do you distil the huge range of data available into reliable, persuasive evidence and actionable intelligence? How can it be applied to underpin your research, pricing and life cycle management decision making?

Harnessing the Power of Real-World Data is essential reading for market access, sales and R&D planners. Packed with insights, case studies and actionable information, this report identifies the critical issues, “must haves” and challenges of establishing and exploiting effective real world data and evidence strategies. The report is based on the insights and experiences of data analytic and medical affairs professionals working in or with US/European pharma companies see who they are.

“Without good analysis and interpretation, data are just facts and figures without useful meaning or insight”


PurchaseReasons

Answering key questions


Creating evidence: How can real world data be turned into compelling evidence and what are the main opportunities arising from its analysis and interpretation?
Sources of real world data: What are the sources of real world data and what are the challenges in collecting them?
Patient power: Patient reported outcomes are becoming increasingly influential, but data quality is variable. How do you reliably incorporate this rich data source in your analysis?
Partnering for advantage: Accessing real world data means government, payers, patients and industry must collaborate. What role can industry play in establishing these relationships?
Working with payers: What role can real world data and evidence play in supporting pricing decisions, ensuring formulary inclusion and securing reimbursement?
Technology drivers: How is digital technology revolutionising the ways data is being collected analysed and disseminated, and how might this develop in the future?
Improving research planning: How is real world data helping to refine clinical trial planning and at what development stage should companies be employing real world data inputs?
Life cycle management: Real world population data can reveal safety issues and potential new indications. How can you incorporate these into a product’s development strategy?


With this report you will be able to:


Learn from detailed case studies about the role played by real world data in, for example, the UK’s MS Risk-sharing scheme and Salford Lung Study, safety findings with saxagliptin in the US and the Electronic Health Records for Clinical Research project in the EU.
Drive commercial success by creating compelling evidence based insights that support your brand and position.
Understand how and where real world data is having significant impact on pharma’s operations.
Know the sources of real world data and the challenges of analysing and interpreting them.
Engage with payers and patients to harness the critical data that can lead to better outcomes.
Gather better information through improved patient support programmes and technology.
Apply real world data and evidence to refine and align you R&D programme to meeting regulator, physician, payer and patient needs.

Key Topics explored

It is critical to ask the right questions to get the right answers that support your brand - project planning is crucial.
Real world data can play a valuable role in combination with formal clinical trials results in securing marketing authorisation, market access and a profitable future for your brand.
While the amount of data available to industry is increasing, concerns remain about patient confidentiality.
The more data that are created the more data “noise” is generated – expert analysis is critical.
Long-term studies based on real world data give a more accurate picture about patient adherence life style choices and behaviour


Expert Contributors

Dr Robin Munro is Director, Real World Evidence and Outcomes, Zephyr Health, UK.
Nigel Hughes is Director for Integrative Healthcare Informatics at Janssen R&D (Johnson & Johnson), Belgium
Florent Richy is Head of Global Epidemiology, Merck Serono (Merck KGaA), Germany
Andy Jones is Vice President of Pharmaceutical Innovation at AstraZeneca, UK
Brian Schwartz is Senior Medical Director at Intarcia Therapeutics, US
Edward Tuttle is Managing Principal at Analysis Group, San Francisco, US
Dr David Leather is Global Medical Affairs Leader, GlaxoSmithKline, UK
Shailja Dixit is Executive Director, Medical Affairs, Allergan, US (The opinions expressed by Dr Dixit represent her personal views and not those of her corporation)
A market access expert from a global top 20 pharmaceutical company. He requested anonymity.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.

ref:plp2016

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on